Mathias Schneeweiss‐Gleixner

Author

Also Known As

Claude Matuchansky, M Schneewei-Gleixner, M Schneeweiß-Gleixner, M. Schneeweiss, M. Schneeweiß-Gleixner, Mathias A Schneeweiss, Mathias A. Schneeweiss, Mathias Schneeweiss, Mathias Schneeweiss-Gleixner, Mathias Schneeweiss‐Gleixner

Publications

937

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna Ludwig Boltzmann Institute for Cardiovascular Research University of Veterinary Medicine Vienna Heidelberg University University Medical Centre Mannheim

About

Mathias Schneeweiss‐Gleixner is an author at Medical University of Vienna specializing in caloric restriction, medicine, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	18
2	Medicine	1	1	18
3	Clinical Nutrition	1	1	18
4	Diabetes	1	1	18
5	Gastroenterology	1	1	18

Mathias Schneeweiss‐Gleixner

Publications

379

Citations

H-Index

Page 1

	Year	Citations
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver disease Lukas Hartl, Katharina Haslinger, Martin Angerer, Hepatology	2022	72
Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019 Martina Hermann, Daniel Laxar, Christoph Krall, Annals of Intensive Care	2022	63
Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis Katharina Blatt, Sabine Cerny‐Reiterer, Juliana Schwaab, Blood	2015	55
Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1 T315I-compound mutations Karoline V. Gleixner, Yüksel Filik, Daniela Berger, PubMed Central	2021	41
Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia Karoline V. Gleixner, Mathias Schneeweiss‐Gleixner, Gregor Eisenwort, Haematologica	2017	39
The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis Mathias Schneeweiss‐Gleixner, Barbara Peter, Siham Bibi, Haematologica	2018	37
CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1T315I+ clones in TKI-resistant CML Mathias Schneeweiss‐Gleixner, Konstantin Byrgazov, Gabriele Stefanzl, EBioMedicine	2019	21
Use of the CytoSorb adsorber in patients with acute-on-chronic liver failure Patrick Haselwanter, Bernhard Scheiner, Lorenz Balcar, Scientific Reports	2024	20
Different enteral nutrition formulas have no effect on glucose homeostasis but on diet-induced thermogenesis in critically ill medical patients: a randomized controlled trial Marlene Wewalka, Andreas Drolz, Berit Seeland, European Journal of Clinical Nutrition Caloric RestrictionNutritionDiet-induced ThermogenesisEnergy HomeostasisIll Medical Patients	2018	18
The Multi-Kinase Inhibitor DCC-2618 Inhibits Proliferation and Survival of Neoplastic Mast Cells and Other Cell Types Involved in Systemic Mastocytosis Mathias Schneeweiss‐Gleixner, Barbara Peter, Katharina Blatt, Blood	2016	13

Page 1